We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
The New Variant Assessment Platform (NVAP) is an offer of UK capacity and expertise to detect and assess new variants of SARS-CoV-2 around the world.
Information on variants of the SARS-CoV-2 virus.
This guidance specifies the standards for the continuous monitoring and sampling of stack emissions.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Latest updates on SARS-CoV-2 variants detected in the UK.
Details the government's response to parts 1 and 2 of Dame Carol Black's independent review of drugs.
How to use a quasi-experimental study to evaluate your digital health product.
The review will examine the harm that drugs cause and look at prevention, treatment and recovery.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.